Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Slusher

Showing results (571-580 of 672) with videos related to

Pageof 68
Sort By:
Journal of Medicinal Chemistry|October 30, 2019
Structure-Activity Relationships for a Series of (Bis(4-fluorophenyl)methyl)sulfinyl Alkyl Alicyclic Amines at the Dopamine Transporter: Functionalizing the Terminal Nitrogen Affects Affinity, Selectivity, and Metabolic StabilityRachel D Slack, Therese C Ku, Jianjing Cao, et al.
Current Drug Metabolism|September 7, 2021
Glutamine Antagonist GA-607 Causes a Dramatic Accumulation of FGAR which can be used to Monitor Target EngagementJesse Alt, Sadakatali S Gori, Kathryn M Lemberg, et al.
Neuropharmacology|April 12, 2019
The highly selective dopamine D<sub>3</sub>R antagonist, R-VK4-40 attenuates oxycodone reward and augments analgesia in rodentsChloe J Jordan, Bree Humburg, Myra Rice, et al.
The Lancet. Global Health|September 2, 2018
Filtered sunlight versus intensive electric powered phototherapy in moderate-to-severe neonatal hyperbilirubinaemia: a randomised controlled non-inferiority trialTina M Slusher, Hendrik J Vreman, Ann M Brearley, et al.
Rapid Communications in Mass Spectrometry : RCM|June 12, 2024
Development of a high-throughput dual-stream liquid chromatography-tandem mass spectrometry method to screen for inhibitors of glutamate carboxypeptidase IINate Hoxie, Yixuan Qiu, Stephen C Kales, et al.
The American Journal of Tropical Medicine and Hygiene|February 9, 2026
Neonatal Sepsis: Etiology, Antimicrobial Susceptibility, and Treatment Outcomes in a Tertiary Hospital in Jos, NigeriaDavid Danjuma Shwe, Udochukwu Michael Diala, Patience Ungut Kanhu, et al.
Journal of Medicinal Chemistry|January 23, 2025
Discovery of Orally Available Prodrugs of Itaconate and DerivativesChae Bin Lee, Ivan Šnajdr, Lukáš Tenora, et al.
Bioorganic & Medicinal Chemistry|December 16, 2018
Structural and computational basis for potent inhibition of glutamate carboxypeptidase II by carbamate-based inhibitorsCyril Barinka, Zora Novakova, Niyada Hin, et al.
Journal of Medicinal Chemistry|April 14, 2016
Unprecedented Binding Mode of Hydroxamate-Based Inhibitors of Glutamate Carboxypeptidase II: Structural Characterization and Biological ActivityZora Novakova, Krystyna Wozniak, Andrej Jancarik, et al.
Journal of Medicinal Chemistry|April 2, 2005
Enantiospecificity of glutamate carboxypeptidase II inhibitionTakashi Tsukamoto, Pavel Majer, Dilrukshi Vitharana, et al.
Pageof 68

Showing results (571-580 of 672) with videos related to

Sort By:
Pageof 68
Journal of Medicinal Chemistry|October 30, 2019
Structure-Activity Relationships for a Series of (Bis(4-fluorophenyl)methyl)sulfinyl Alkyl Alicyclic Amines at the Dopamine Transporter: Functionalizing the Terminal Nitrogen Affects Affinity, Selectivity, and Metabolic StabilityRachel D Slack, Therese C Ku, Jianjing Cao, et al.
Current Drug Metabolism|September 7, 2021
Glutamine Antagonist GA-607 Causes a Dramatic Accumulation of FGAR which can be used to Monitor Target EngagementJesse Alt, Sadakatali S Gori, Kathryn M Lemberg, et al.
Neuropharmacology|April 12, 2019
The highly selective dopamine D<sub>3</sub>R antagonist, R-VK4-40 attenuates oxycodone reward and augments analgesia in rodentsChloe J Jordan, Bree Humburg, Myra Rice, et al.
The Lancet. Global Health|September 2, 2018
Filtered sunlight versus intensive electric powered phototherapy in moderate-to-severe neonatal hyperbilirubinaemia: a randomised controlled non-inferiority trialTina M Slusher, Hendrik J Vreman, Ann M Brearley, et al.
Rapid Communications in Mass Spectrometry : RCM|June 12, 2024
Development of a high-throughput dual-stream liquid chromatography-tandem mass spectrometry method to screen for inhibitors of glutamate carboxypeptidase IINate Hoxie, Yixuan Qiu, Stephen C Kales, et al.
The American Journal of Tropical Medicine and Hygiene|February 9, 2026
Neonatal Sepsis: Etiology, Antimicrobial Susceptibility, and Treatment Outcomes in a Tertiary Hospital in Jos, NigeriaDavid Danjuma Shwe, Udochukwu Michael Diala, Patience Ungut Kanhu, et al.
Journal of Medicinal Chemistry|January 23, 2025
Discovery of Orally Available Prodrugs of Itaconate and DerivativesChae Bin Lee, Ivan Šnajdr, Lukáš Tenora, et al.
Bioorganic & Medicinal Chemistry|December 16, 2018
Structural and computational basis for potent inhibition of glutamate carboxypeptidase II by carbamate-based inhibitorsCyril Barinka, Zora Novakova, Niyada Hin, et al.
Journal of Medicinal Chemistry|April 14, 2016
Unprecedented Binding Mode of Hydroxamate-Based Inhibitors of Glutamate Carboxypeptidase II: Structural Characterization and Biological ActivityZora Novakova, Krystyna Wozniak, Andrej Jancarik, et al.
Journal of Medicinal Chemistry|April 2, 2005
Enantiospecificity of glutamate carboxypeptidase II inhibitionTakashi Tsukamoto, Pavel Majer, Dilrukshi Vitharana, et al.
Pageof 68